Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:11
Article PubMed PubMed Central Google Scholar
Kremastinos DT (2001) Heart failure in β-thalassemia. Congest Heart Fail 7:312–314
Ghanavat M, Haybar H, Pezeshki SMS et al (2020) Cardiomyopathy in thalassemia: quick review from cellular aspects to diagnosis and current treatments. Lab Med 51:143–150
Albakri A (2018) Iron overload cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnostic and clinical management using iron chelators. Int Med Care. https://doi.org/10.15761/IMC.1000117
Kumfu S, Chattipakorn SC, Chattipakorn N (2022) Iron overload cardiomyopathy: using the latest evidence to inform future applications. Exp Biol Med (Maywood) 247:574–583
Article CAS PubMed Google Scholar
Borgna-Pignatti C, Rugolotto S, De Stefano P et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193
Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42
Article PubMed PubMed Central Google Scholar
Pepe A, Pistoia L, Gamberini MR et al (2022) National networking in rare diseases and reduction of cardiac burden in thalassemia major. Eur Heart J 43:2482–2492
McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) With the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 42:3599–3726
Article CAS PubMed Google Scholar
Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 145:e895–e1032
Matusik PS, Bryll A, Matusik PT, Popiela TJ (2021) Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction. Cardiol J 28:67–76
Article PubMed PubMed Central Google Scholar
Meloni A, Saba L, Positano V et al (2024) Left atrial strain in patients with beta-thalassemia major: a cross-sectional CMR study. Eur Radiol. https://doi.org/10.1007/s00330-024-10667-x
Rezaeian N, Mohtasham MA, Khaleel AJ, Parnianfard N, Kasani K, Golshan R (2020) Comparison of global strain values of myocardium in beta-thalassemia major patients with iron load using specific feature tracking in cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 36:1343–1349
Meloni A, Pistoia L, Positano V et al (2023) Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. Eur Radiol 33:1266–1276
Article CAS PubMed Google Scholar
Meloni A, Pistoia L, Positano V et al (2023) Myocardial tissue characterization by segmental T2 mapping in thalassaemia major: detecting inflammation beyond iron. Eur Heart J Cardiovasc Imag 24:1222–1230
Ibrahim HR, Ahmed AT (2023) Role of cardiac magnetic resonance T1 mapping in comparison to T2* for cardiac iron overload assessment in transfusion-dependent thalassemia major patients. Egy J Radiol Nucl Med 54:197
Meloni A, Positano V, Ruffo GB et al (2015) Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy. Eur Heart J Cardiovasc Imag 16:325–334
Miller CA, Pearce K, Jordan P et al (2012) Comparison of real-time three-dimensional echocardiography with cardiovascular magnetic resonance for left ventricular volumetric assessment in unselected patients. Eur Heart J Cardiovasc Imag 13:187–195
Pennell DJ (2010) Cardiovascular magnetic resonance. Circulation 121:692–705
Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179
Article CAS PubMed Google Scholar
Tanner MA, Galanello R, Dessi C et al (2008) Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 10:12
Article PubMed PubMed Central Google Scholar
Anderson LJ, Westwood MA, Holden S et al (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127:348–355
Article CAS PubMed Google Scholar
Meloni A, Pistoia L, Gamberini MR et al (2023) Multi-parametric cardiac magnetic resonance for prediction of heart failure death in thalassemia major. Diagnostics (Basel) 13:890
Article CAS PubMed Google Scholar
Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B et al (2020) Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22:87
Article PubMed PubMed Central Google Scholar
Leiner T, Bogaert J, Friedrich MG et al (2020) SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 22:76
Article PubMed PubMed Central Google Scholar
Alpendurada F, Carpenter JP, Deac M et al (2010) Relation of myocardial T2* to right ventricular function in thalassaemia major. Eur Heart J 31:1648–1654
Liguori C, Pitocco F, Di Giampietro I et al (2015) Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients. Biomed Res Int 2015:857642
Article PubMed PubMed Central Google Scholar
Westwood MA, Anderson LJ, Maceira AM et al (2007) Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. J Magn Reson Imaging 25:1147–1151
Carpenter JP, Alpendurada F, Deac M et al (2010) Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload. J Cardiovasc Magn Reson 12:24
Article PubMed PubMed Central Google Scholar
Meloni A, Righi R, Missere M et al (2021) Biventricular reference values by body surface area, age, and gender in a large cohort of well-treated thalassemia major patients without heart damage using a multiparametric CMR approach. J Magn Reson Imag 53:61–70
Mewton N, Opdahl A, Choi EY et al (2013) Left ventricular global function index by magnetic resonance imaging–a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension 61:770–778
Article CAS PubMed Google Scholar
Meloni A, Positano V, Pistoia L et al (2023) Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients. Int J Cardiovasc Imaging 39:991–999
Pezel T, Venkatesh BA, Vasconcellos HDD et al (2021) Left atrioventricular coupling index as a prognostic marker of cardiovascular events: the MESA study. Hypertension 78:661–671
Article CAS PubMed Google Scholar
von Roeder M, Kowallick JT, Rommel K-P et al (2020) Right atrial–right ventricular coupling in heart failure with preserved ejection fraction. Clin Res Cardiol 109:54–66
Meloni A, Saba L, Positano V et al (2024) Left and right atrioventricular coupling index in patients with beta-thalassemia major. Int J Cardiovasc Imaging. https://doi.org/10.1007/s10554-024-03146-3
留言 (0)